5-Hydroxytryptophan in Friedreich’s Ataxia

J Gordon Millichap

doi:10.15844/pedneurbriefs-9-6-6

5-Hydroxytryptophan in Friedreich’s Ataxia

Pediatric Neurology Briefs

Volume 9 (1995): Issue 6

By: J Gordon Millichap

Open Access

|Jun 1995

Abstract

The effect of the levorotatory form of 5-hydroxytryptophan (approx 1 gm/day/orally) on cerebellar symptoms in 26 patients with Friedreich’s ataxia was evaluated in a double-blind drug-placebo study by the Ataxia Research Center, Hopital Neurologique, Lyon and 11 other research hospitals in France.

References

Trouillas P Serratrice G Laplane D Rascol A Augustin P Barroche G Levorotatory form of 5-hydroxytryptophan in Friedreich’s ataxia Arch Neurol 1995 May 52 5 456 460 10.1001/archneur.1995.00540290042016 7733839
Open DOI Search in Google Scholar Back to article
Wessel K Hermsdorfer J Deger K Herzog T Huss GP Kompf D Double-blind crossover study with levorotatory form of hydroxytryptophan in patients with degenerative cerebellar diseases Arch Neurol 1995 May 52 5 451 455 10.1001/archneur.1995.00540290037015 7733838
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-9-6-6 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 44 - 45

Published on: Jun 1, 1995

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

5-Hydroxytryptophan,

Cerebellar Symptoms,

Friedreich’s Ataxia

© 1995 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 9 (1995): Issue 6